Zhong Guo Xin Wen Wang·2025-11-05 07:47Group 1 - The 8th China International Import Expo (CIIE) opened in Shanghai on November 5, showcasing innovative products from several multinational pharmaceutical companies [1] - Eli Lilly presented multiple global innovative drugs, including the oral selective estrogen receptor degrader Imlunestrant for breast cancer and the injectable tirzepatide for cardiovascular metabolic health, marking their debut at the expo [1] - Eli Lilly's Vice President and General Manager for China emphasized the importance of collaboration with government, clinical institutions, and industry partners to enhance healthcare development through the CIIE platform [1] Group 2 - Bayer showcased 26 highlight exhibits at its 800-square-meter dual exhibition booth, focusing on innovations in healthcare and agricultural technology [1] - In the imaging diagnostics sector, Bayer's MEDRAD Stellant D-CE high-pressure injection system made its debut at the expo after receiving local production approval in June [1] - Merck displayed approximately 30 approved drugs and vaccines at the expo, including several innovative drugs and new indications, benefiting from the expo's spillover effect [2] Group 3 - Merck's participation has led to the approval of multiple investigational drugs in China, providing new treatment options for patients with antibiotic-resistant infections and rare diseases [2] - The company is advancing clinical research in various therapeutic areas in China and plans to introduce over 40 new products and indications in the next five years [2]